Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crexendo (CXDO) Non-Current Deffered Revenue (2016 - 2025)

Crexendo's Non-Current Deffered Revenue history spans 15 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue rose 244.03% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, up 244.03%, while the annual FY2025 figure was $1.0 million, 244.03% up from the prior year.
  • Non-Current Deffered Revenue reached $1.0 million in Q4 2025 per CXDO's latest filing, up from $359000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.0 million in Q4 2025 to a low of $181000.0 in Q2 2025.
  • Average Non-Current Deffered Revenue over 5 years is $297785.7, with a median of $237000.0 recorded in 2022.
  • Peak YoY movement for Non-Current Deffered Revenue: tumbled 35.56% in 2021, then soared 244.03% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $290000.0 in 2021, then dropped by 14.83% to $247000.0 in 2022, then decreased by 19.84% to $198000.0 in 2023, then surged by 47.98% to $293000.0 in 2024, then skyrocketed by 244.03% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for CXDO's Non-Current Deffered Revenue are $1.0 million (Q4 2025), $359000.0 (Q3 2025), and $181000.0 (Q2 2025).